DaVita Inc. (FRA:TRL)

Germany flag Germany · Delayed Price · Currency is EUR
100.30
-0.55 (-0.55%)
Last updated: Dec 4, 2025, 6:00 PM CET
-35.52%
Market Cap 7.12B
Revenue (ttm) 11.35B
Net Income (ttm) 657.90M
Shares Out n/a
EPS (ttm) 8.32
PE Ratio 10.83
Forward PE 9.51
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 22
Open 101.05
Previous Close 100.85
Day's Range 100.30 - 101.05
52-Week Range 98.70 - 172.05
Beta n/a
RSI 41.23
Earnings Date Feb 13, 2026

About DaVita

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition... [Read more]

Industry Miscellaneous Health And Allied Services, Not Elsewhere Classified
Founded 1994
Employees 76,000
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol TRL
Full Company Profile

Financial Performance

In 2024, DaVita's revenue was $12.82 billion, an increase of 5.56% compared to the previous year's $12.14 billion. Earnings were $936.34 million, an increase of 35.40%.

Financial numbers in USD Financial Statements

News

There is no news available yet.